Background Pancreatic cancer is projected to become the second leading cause of cancer
related death in the US. We aim to investigate the demographics, clinical outcomes and …

Background Pancreatic cancer is uncommon in patients younger than 50 years, although its
incidence is increasing. This study characterizes treatment utilization for early‐onset …

Background Early-onset pancreatic cancer (< 50 years, EOPC) is uncommon and limited
data exist on clinical presentation and long-term survival. The aim of this study was to …

Background Pancreatic cancer incidence is increasing in younger populations. Differences
between early onset pancreatic cancer (EOPC) and later onset pancreatic cancer (LOPC) …

Background The aim of this study was to compare trends in mortality and incidence,
clinicopathological features and survival of patients diagnosed with pancreatic ductal …

Diagnosed before age 50, early onset pancreatic malignancy (EOPM), is hypothesized to be
a distinct subset of disease, although research is limited. To better characterize EOPM, and …

Objectives Pancreatic cancer continues to carry a poor prognosis with survival rates that
have had minimal improvement over the past 4 decades. We report a population-based …

Purpose Pancreatic cancer is one of the most fatal malignancies and the fourth leading
cause of cancer-related mortality in the USA. Most clinical trials involving pancreatic …

Background: Pancreatic ductal adenocarcinoma (PDAC) is a rare and refractory malignancy.
Early-onset pancreatic cancer (EOPC), defined as pancreatic cancer diagnosed before the …

Results A total of 423,482 patients between 2004 and 2017 were included in the study.
Patients aged between 18 and 40-years-old had the worst 3-year survival rate among stage …